Insurance

3 Things You Must Know About Integrated Shield Plans

With rising healthcare costs and the new co-payment shield riders, will you still be able to afford your medical bills?

  • iFAST Insurance Team
  • |
  • Published on 16 Mar 2018

With Singapore's medical inflation rate exceeding global standards, falling sick in Singapore is no doubt an expensive affair.1 To ensure that you would be able to afford future hospitalisation and/or treatment costs, it is therefore important for you to have health insurance. However, with new co-payment riders soon to replace existing full Integrated Shield Plan (IP) riders, you may have to fork out more for your future medical bills. As such, will your existing coverage still be sufficient in the event of an illness?

(See "The 3 Best Policies For Every Life Stage")

#1 The mechanics of Shield plans

A national health insurance scheme, Medishield Life provides basic health coverage for all Singaporeans and Permanent Residents (PRs). While Medishield Life does not restrict your ward choice, coverage levels are based on the treatment costs for Class B2 or C wards at public hospitals. Hence, should the insured choose to receive treatment in a Class B2 or C ward at a public hospital, he/she can expect Medishield Life to cover the majority of his bills. Co-payment would then only be required for the deductible and co-insurance components.

However, should you wish to receive treatment in private hospitals and/or Class A wards in public hospitals, consider upgrading to an IP. Integrated shield riders that cover the cost of co-insurance and deductibles can also be purchased should you wish to receive additional coverage for your medical bills.

(See "The Secret Behind Avoiding Expensive Medical Bills")

#2 The new Integrated Shield Plan riders

With the new IP riders to be introduced by April 2019, here are a few key points to note.

Firstly, the new riders are set to impose a minimum 5 per cent co-payment. This means that as compared to the current riders where the insured do not pay a single cent for the treatment received, he/she would not be able to do so in future. This is likely to affect the 71 per cent of Singaporeans who do not have full riders.2

Secondly, Singaporeans can still continue to purchase the existing rider plans from now till 1 April 2019. However, this would only be temporary with the insured required to switch over to the new riders by 1 April 2021. Additionally, the new riders are expected to have lower premiums which may make premiums more affordable.

Lastly, those with the full IP riders would remain unaffected for now. However, this does not put co-paying out of the picture as future changes may be made.

(See "Want An Early Retirement? Find Out How Much It Costs")

#3 How this affects you

While consumers are expected to only feel the difference starting from April next year, planning now could help you to better prepare for the impending change. This is because you would no longer be able to receive full coverage for your hospitalisation costs with the implementation of co-payments. As such, would your coverage still be sufficient in the event of an illness or medical need?

For starters, consider enhancing your coverage with a critical illness policy. Providing a lump sum pay-out in the event of a diagnosis, this pay-out could help to offset your co-payment or supplement any medical expenses that you may incur. Additionally, a regular review of your insurance portfolio also ensures that your policies are kept relevant and adequate for your needs.

(See "Comparing Critical Illness Policies")

How FSMOne can help you get on track

Our team of friendly advisers are able to help you review your financial objectives, long term commitments, and offer you investment and insurance advice specific to your needs. If you would like assistance in reviewing your financial and protection portfolio, or simply to get a quote for an insurance plan,

Contact Our Advisors Here >

Available Products on FSMOne Insurance

Term Life, Whole Life, Critical Illness, Annuity, Health, Endowment


from Etiqa Insurance, Manulife, NTUC Income and Tokio Marine Life Insurance


*Please check with our advisory team if the product you want is available on FSMOne Insurance

1Source: http://www.aon.com/attachments/human-capital-consulting/2017_GB_Trends_brochure_20170105.pdf


2Source: https://www.channelnewsasia.com/news/singapore/5-per-cent-co-payment-new-integrated-shield-riders-10021398


Interested to learn more? Check out these articles:

All You Need To Know About Personal Accident Plans

5 Ideas That Can (Almost...) Give You An Income For Life

Comparing Cancer-specific Policies

Want An Early Retirement? Find Out How Much It Costs

Can You Survive A $300,000 Medical Bill?

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.


Ways to Invest with FSM Global
Why FSM Global
Don't have an account with us?
Open an account here
Need Financial Advice?
Make an appointment
Related Articles More

We use cookies If you close this message or continue to use this site, you will consent to the use of Cookies, unless you choose to disable them. Click on our Privacy Policy to understand more.